Accumulating evidence suggests that alloreactive memory T cells (Tm) may be generated in transplant recipients that have not previously been exposed to alloantigen through mechanisms such as cross-reactivity and homeostatic proliferation. The presence of Tm correlates with both acute and chronic rejection episodes and, furthermore, may be responsible for the failure to induce tolerance in large animal and clinical settings. A clearer understanding of how Tm function and their requirements to mount an effective response to alloantigen will be key to further attempts to translate tolerance induction protocols from the experimental setting to the clinic
ory ael 376 Update TRENDS in Immunology Vol.28 No.9presented by HLA-B8 respond to three allogeneic H...
The long-term success of transplantation is limited by the need for immunosuppression; thus, toleran...
In order to prevent allograft rejection, most current immunosuppressive drugs nonspecifically target...
Memory T cells are characterized by their low activation threshold, robust effector functions, and r...
Accumulating evidence suggests that alloreactive memory T cells (Tm) may form a barrier to tolerance...
Alloreactive memory T cells may be refractory to many of the tolerance-inducing strategies that are ...
Solid organ transplantation is widely accepted as an effective treatment for end organ failure. Alth...
The presence of alloreactive memory T cells in recipient is a critical handicap to achieving transpl...
Memory cells are currently thought to be a major barrier to tolerance induction in transplantation. ...
While the development of powerful immunosuppressive medications enabled the use of organ transplanta...
During the last few decades our knowledge of transplantation has been remarkably expanded to the poi...
Allogeneic tissues transplanted to mice treated with CD4- and CD8-specific Abs are often accepted in...
It has long been appreciated that MHC alloantigens can be recognized via two pathways; direct and in...
In order to prevent allograft rejection, most current immunosuppressive drugs nonspecifically target...
The term allorecognition refers to the series of mechanisms used by an individual’s immune system to...
ory ael 376 Update TRENDS in Immunology Vol.28 No.9presented by HLA-B8 respond to three allogeneic H...
The long-term success of transplantation is limited by the need for immunosuppression; thus, toleran...
In order to prevent allograft rejection, most current immunosuppressive drugs nonspecifically target...
Memory T cells are characterized by their low activation threshold, robust effector functions, and r...
Accumulating evidence suggests that alloreactive memory T cells (Tm) may form a barrier to tolerance...
Alloreactive memory T cells may be refractory to many of the tolerance-inducing strategies that are ...
Solid organ transplantation is widely accepted as an effective treatment for end organ failure. Alth...
The presence of alloreactive memory T cells in recipient is a critical handicap to achieving transpl...
Memory cells are currently thought to be a major barrier to tolerance induction in transplantation. ...
While the development of powerful immunosuppressive medications enabled the use of organ transplanta...
During the last few decades our knowledge of transplantation has been remarkably expanded to the poi...
Allogeneic tissues transplanted to mice treated with CD4- and CD8-specific Abs are often accepted in...
It has long been appreciated that MHC alloantigens can be recognized via two pathways; direct and in...
In order to prevent allograft rejection, most current immunosuppressive drugs nonspecifically target...
The term allorecognition refers to the series of mechanisms used by an individual’s immune system to...
ory ael 376 Update TRENDS in Immunology Vol.28 No.9presented by HLA-B8 respond to three allogeneic H...
The long-term success of transplantation is limited by the need for immunosuppression; thus, toleran...
In order to prevent allograft rejection, most current immunosuppressive drugs nonspecifically target...